Evofem Biosciences, Inc. 8-K

What Happened
On March 11, 2026, Evofem Biosciences, Inc. announced its financial results for the year ended December 31, 2025 by issuing a press release that was furnished with the company’s Form 8‑K (Exhibit 99.1). At the same time, Evofem posted a current corporate slide presentation to the Investors section of its website and furnished those slides as Exhibit 99.2 to the 8‑K (presentation prepared as of March 11, 2026).

Key Details

• Press release announcing full-year 2025 financial results was furnished on March 11, 2026 as Exhibit 99.1.
• Corporate slide presentation dated March 11, 2026 was posted to www.evofem.com (Investors) and furnished as Exhibit 99.2.
• The press release content is furnished (not filed) under the Exchange Act and is not incorporated by reference into other filings, per the company statement.
• The company stated it has no obligation to update or supplement the slide presentation after posting.

Why It Matters
This 8‑K is a routine disclosure that directs investors to the company’s year‑end results and investor materials. Retail investors should review the press release and slide deck for the actual earnings, revenue, guidance or other financial metrics, as the 8‑K itself furnishes those materials rather than embedding detailed figures. Because the materials are furnished (not filed), they are provided for information but are not incorporated by reference into other SEC filings. Look for follow‑up documents (e.g., 10‑K, earnings calls) for audited financial statements and additional details.